For Blood Brother Michael Eck, community wasn't always a big part of his life with a bleeding disorder. For years, he barely engaged with it. Now, as he's gotten older, that relationship has changed, and Michael joins us to talk about what brought him back and why the connection looks different today.
We're also joined by Robyn Kebede, HFA's Education Manager, to talk about what's happening across the organization, where their programming is headed, and what they're hearing from the community right now.
Two guests, two perspectives, and one big reminder: there's no right time, right way, or one-size-fits-all approach to finding your community.
Find your favorite listening spot, because this is one you'll want to hang out with us for!
Show Notes:
Hemophilia Federation of America
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
For Blood Brother Michael Eck, community wasn't always a big part of his life with a bleeding disorder. For years, he barely engaged with it. Now, as he's gotten older, that relationship has changed, and Michael joins us to talk about what brought him back and why the connection looks different today.
We're also joined by Robyn Kebede, HFA's Education Manager, to talk about what's happening across the organization, where their programming is headed, and what they're hearing from the community right now.
Two guests, two perspectives, and one big reminder: there's no right time, right way, or one-size-fits-all approach to finding your community.
Find your favorite listening spot, because this is one you'll want to hang out with us for!
Show Notes:
Hemophilia Federation of America
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Ranvitha Chirumamilla joins us to explore how her own experience with iron-deficiency anemia sparked an interest in women with bleeding disorders and a bigger question: when factor levels don't raise enough concern, who might be getting missed?
And our blood brother Reid Morgan is back for I'm Fine! A handful of years after sharing his story with us publicly for the first time, Reid reflects on what "I'm fine" has meant to him and what happens when an illness that has shaped so much of your identity starts to feel like less of the story.
So grab your headphones and join Ranvitha and Reid for two thoughtful, very different conversations about being seen, being heard, and figuring out who we are along the way.
Show Notes:
Novo flags FDA hemophilia review extension tied to manufacturing site corrections
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
Ranvitha Chirumamilla joins us to explore how her own experience with iron-deficiency anemia sparked an interest in women with bleeding disorders and a bigger question: when factor levels don't raise enough concern, who might be getting missed?
And our blood brother Reid Morgan is back for I'm Fine! A handful of years after sharing his story with us publicly for the first time, Reid reflects on what "I'm fine" has meant to him and what happens when an illness that has shaped so much of your identity starts to feel like less of the story.
So grab your headphones and join Ranvitha and Reid for two thoughtful, very different conversations about being seen, being heard, and figuring out who we are along the way.
Show Notes:
Novo flags FDA hemophilia review extension tied to manufacturing site corrections
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, we're diving into both. Tim Stowers, fellow blood brother and history-making Channel swimmer, joins our hosts with his sister Vanessa and nephew Elias to share the story behind his incredible open-water swim.
Then, in honor of ITP Awareness Month, Caroline Kruse, CEO & President of the Platelet Disorders Support Association, joins us to talk about ITP, the platelet disorders community, and the stories that deserve a bigger spotlight.
Show Notes:
Platelet Disorders Support Association
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, we're diving into both. Tim Stowers, fellow blood brother and history-making Channel swimmer, joins our hosts with his sister Vanessa and nephew Elias to share the story behind his incredible open-water swim.
Then, in honor of ITP Awareness Month, Caroline Kruse, CEO & President of the Platelet Disorders Support Association, joins us to talk about ITP, the platelet disorders community, and the stories that deserve a bigger spotlight.
Show Notes:
Platelet Disorders Support Association
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Patrick and Amy explore the personal decisions behind research participation.
Kevin Finkle joins the I'm Fine segment to share his experience participating in multiple clinical studies and what has shaped his decision to keep getting involved. Later, Benny Sorensen, MD, PhD, CEO of Hemab Therapeutics, offers a look at the role patients play in moving research forward and why asking questions matters.
Whether you've participated in research, are considering a study, or have simply wondered, "Are clinical trials for me?" this episode is for you.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Patrick and Amy explore the personal decisions behind research participation.
Kevin Finkle joins the I'm Fine segment to share his experience participating in multiple clinical studies and what has shaped his decision to keep getting involved. Later, Benny Sorensen, MD, PhD, CEO of Hemab Therapeutics, offers a look at the role patients play in moving research forward and why asking questions matters.
Whether you've participated in research, are considering a study, or have simply wondered, "Are clinical trials for me?" this episode is for you.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Gorana Dasic of Kedrion Biopharma is featured on Movers & Shakers of Rare, and Archit Gupta from Zebra for Care joins Patrick James Lynch and Amy Board to explore the ideas, innovations, and collaborations helping create a more connected experience for patients and families.
Archit Gupta from Zebra for Care joins the conversation to discuss a new model for supporting patients and building resources that meet people where they are in their healthcare journey.
From advocacy and innovation to new approaches in care, this episode highlights the people working to make the rare disease experience more connected, informed, and patient-focused.
Show Notes:
Zebra for Care
Movers & Shakers in Rare
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Gorana Dasic of Kedrion Biopharma is featured on Movers & Shakers of Rare, and Archit Gupta from Zebra for Care joins Patrick James Lynch and Amy Board to explore the ideas, innovations, and collaborations helping create a more connected experience for patients and families.
Archit Gupta from Zebra for Care joins the conversation to discuss a new model for supporting patients and building resources that meet people where they are in their healthcare journey.
From advocacy and innovation to new approaches in care, this episode highlights the people working to make the rare disease experience more connected, informed, and patient-focused.
Show Notes:
Zebra for Care
Movers & Shakers in Rare
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Patrick James Lynch and Amy Board sit down with Jonathan James, founder and CEO of Hope Charities, to explore how connection, community, and shared experiences can make a lasting difference for patients and families. Jonathan shares the story behind Hope Charities, the relationships that inspired its mission, and why creating spaces where people feel seen and supported matters just as much as the programs themselves.
Whether you're living with a bleeding disorder, caring for someone who is, or simply looking for a reminder of the power of community, this conversation is one you won't want to miss.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Patrick James Lynch and Amy Board sit down with Jonathan James, founder and CEO of Hope Charities, to explore how connection, community, and shared experiences can make a lasting difference for patients and families. Jonathan shares the story behind Hope Charities, the relationships that inspired its mission, and why creating spaces where people feel seen and supported matters just as much as the programs themselves.
Whether you're living with a bleeding disorder, caring for someone who is, or simply looking for a reminder of the power of community, this conversation is one you won't want to miss.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Chris returns for another Zebra for Care conversation, sharing why awareness, advocacy, and making sure people living with bleeding disorders feel seen and supported matters now more than ever.
Patrick James Lynch and Amy Board also reflect on the conversations and connections shaping this year's Bleeding Disorders Conference (BDC), sharing what they hope to learn and bring back to patients and families.
In the I'm Fine segment, Carrera Christman opens up about the pressure of always being the strong one and how she learned that asking for help is a strength. As an advocate, community leader, and member of the National Youth Leadership Institute, Carrera explores resilience, vulnerability, and the power of saying, "I'm not fine."
From community connection to honest conversations about mental health, this episode is a reminder that no one has to navigate their journey alone.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Chris returns for another Zebra for Care conversation, sharing why awareness, advocacy, and making sure people living with bleeding disorders feel seen and supported matters now more than ever.
Patrick James Lynch and Amy Board also reflect on the conversations and connections shaping this year's Bleeding Disorders Conference (BDC), sharing what they hope to learn and bring back to patients and families.
In the I'm Fine segment, Carrera Christman opens up about the pressure of always being the strong one and how she learned that asking for help is a strength. As an advocate, community leader, and member of the National Youth Leadership Institute, Carrera explores resilience, vulnerability, and the power of saying, "I'm not fine."
From community connection to honest conversations about mental health, this episode is a reminder that no one has to navigate their journey alone.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
#HYMPAVZISponsored Mosi Williams, PsyD, lives with hemophilia and has served in
the Bleeding Disorders Community for the past 30 years. He is currently a Licensed
Clinical Social Worker for the UCSF Adult Hemophilia Treatment Center.
Mosi joins Patrick to explore the evolving treatment landscape and the anxiety that
critical moments that shape life with hemophilia—like going back to school, starting a
new job, or planning a wedding—can bring, and how they can prompt deeper
consideration of a treatment change. We'll provide listeners with the latest on HYMPAVZI (marstacimab-hncq) and highlight the value of shared decision-making.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic
events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your
arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and
additional safety information visit www.HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This
video is intended to be viewed as it was originally produced in partnership with Pfizer.
Remember, this content is for educational purposes only and does not replace
discussions with a healthcare provider.
PP-HYM-USA-1290
Show Notes:
For safety information
visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-
making Guide: https://webfiles.pfizer.com/HYM-Shared-Decision
Listen and Subscribe where you get your podcasts! #Hemophilia
Important: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>#HYMPAVZISponsored Mosi Williams, PsyD, lives with hemophilia and has served in
the Bleeding Disorders Community for the past 30 years. He is currently a Licensed
Clinical Social Worker for the UCSF Adult Hemophilia Treatment Center.
Mosi joins Patrick to explore the evolving treatment landscape and the anxiety that
critical moments that shape life with hemophilia—like going back to school, starting a
new job, or planning a wedding—can bring, and how they can prompt deeper
consideration of a treatment change. We'll provide listeners with the latest on HYMPAVZI (marstacimab-hncq) and highlight the value of shared decision-making.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic
events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your
arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and
additional safety information visit www.HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This
video is intended to be viewed as it was originally produced in partnership with Pfizer.
Remember, this content is for educational purposes only and does not replace
discussions with a healthcare provider.
PP-HYM-USA-1290
Show Notes:
For safety information
visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-
making Guide: https://webfiles.pfizer.com/HYM-Shared-Decision
Listen and Subscribe where you get your podcasts! #Hemophilia
IMPORTANT SAFETY INFORMATIONImportant: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
What is HYMPAVZI?HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>On this episode of BloodStream, Patrick and Amy explore emerging research that challenges long-held assumptions about factor IX levels during pregnancy and what it could mean for patients and providers. Nathan Mermilliod shares his experience living with hemophilia B, and Dr. Steven Fein discusses the evolving landscape of telemedicine in partnership with Zebra for Care.
From new discoveries to lived experiences, this episode highlights the stories and science moving the bleeding disorders community forward.
Show Notes:
Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On this episode of BloodStream, Patrick and Amy explore emerging research that challenges long-held assumptions about factor IX levels during pregnancy and what it could mean for patients and providers. Nathan Mermilliod shares his experience living with hemophilia B, and Dr. Steven Fein discusses the evolving landscape of telemedicine in partnership with Zebra for Care. From new discoveries to lived experiences, this episode highlights the stories and science moving the bleeding disorders community forward.
Show Notes:
Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On this episode of BloodStream, Patrick facilitates a conversation between Peter, who is living with hemophilia A, and Dr. Tammuella Chrisentery-Singleton, a board-certified hematologist and Chief Science Officer (CSO) for The American Thrombosis and Hemostasis Network (ATHN), to explore the shared decision-making process and why it matters. We'll provide listeners with the latest on HYMPAVZI (marstacimab-hncq) and highlight the value of shared decision-making.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic events).
HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and additional safety information visit HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This video is intended to be viewed as it was originally produced in partnership with Pfizer. Remember, this content is for educational purposes only and does not replace discussions with a healthcare provider.
PP-HYM-USA-1115
Show Notes:
For safety information visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-making Guide here.
Listen and subscribe where you get your podcasts! #Hemophilia
Important: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>On this episode of BloodStream, Patrick facilitates a conversation between Peter, who is living with hemophilia A, and Dr. Tammuella Chrisentery-Singleton, a board-certified hematologist and Chief Science Officer (CSO) for The American Thrombosis and Hemostasis Network (ATHN), to explore the shared decision-making process and why it matters. We'll provide listeners with the latest on HYMPAVZI (marstacimab-hncq) and highlight the value of shared decision-making.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic events).
HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and additional safety information visit HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This video is intended to be viewed as it was originally produced in partnership with Pfizer. Remember, this content is for educational purposes only and does not replace discussions with a healthcare provider.
PP-HYM-USA-1115
Show Notes:
For safety information visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-making Guide here.
Listen and subscribe where you get your podcasts! #Hemophilia
IMPORTANT SAFETY INFORMATIONImportant: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
What is HYMPAVZI?HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>Jeff and Barb return to the podcast with therapist Gary McClain for a thoughtful conversation about the emotional side of living with a rare disease, exploring resilience, difficult emotions, and how we support ourselves and one another.
LevelsMatter.com
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
Jeff and Barb return to the podcast with therapist Gary McClain for a thoughtful conversation about the emotional side of living with a rare disease, exploring resilience, difficult emotions, and how we support ourselves and one another.
Show Notes:LevelsMatter.com
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
#HYMPAVZISponsored William S. Somers, Ph.D., was a biotherapeutics research and development leader with more than 30 years of experience across biotechnology and pharmaceutical organizations, including Pfizer.
As a scientist living with hemophilia, Dr. Somers played a key role in driving the patient-centric and purposeful design of HYMPAVZI (marstacimab-hncq). This episode will explore how the patient perspective influenced the scientific journey, with a special focus on Will's research and why it was personally important for him to bring HYMPAVZI to people with hemophilia.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and additional safety information visit HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This video is intended to be viewed as it was originally produced in partnership with Pfizer. Remember, this content is for educational purposes only and does not replace discussions with a healthcare provider.
PP-HYM-USA-1267
Show Notes:
For safety information visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-making Guide here.
Listen and subscribe where you get your podcasts! #Hemophilia
Important: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>#HYMPAVZISponsored William S. Somers, Ph.D., was a biotherapeutics research and development leader with more than 30 years of experience across biotechnology and pharmaceutical organizations, including Pfizer.
As a scientist living with hemophilia, Dr. Somers played a key role in driving the patient-centric and purposeful design of HYMPAVZI (marstacimab-hncq). This episode will explore how the patient perspective influenced the scientific journey, with a special focus on Will's research and why it was personally important for him to bring HYMPAVZI to people with hemophilia.
HYMPAVZI may cause serious side effects, including blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. To learn more about this risk and additional safety information visit HYMPAVZI.com.
This post is directed to a U.S. audience and may not be suitable outside of the U.S. This video is intended to be viewed as it was originally produced in partnership with Pfizer. Remember, this content is for educational purposes only and does not replace discussions with a healthcare provider.
PP-HYM-USA-1267
Show Notes:
For safety information visit: https://labeling.pfizer.com/ShowLabeling.aspx?id=20916&Section=PPI
For information on how to navigate your treatment journey, visit the Shared Decision-making Guide here.
Listen and subscribe where you get your podcasts! #Hemophilia
IMPORTANT SAFETY INFORMATIONImportant: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or "bypassing agents" (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII or factor IX medicines or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider's instructions regarding when to use these medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:have a planned surgery. Your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
have a severe short-term (acute) illness such as an infection or injury.
have been told that you have a risk for blood clots.
are pregnant or plan to become pregnant. HYMPAVZI may harm your unborn baby.
Your healthcare provider will do a pregnancy test before you start your treatment with HYMPAVZI.
Use effective birth control (contraception) during treatment with HYMPAVZI and for at least 2 months after the last dose of HYMPAVZI.
Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with HYMPAVZI.
are breastfeeding or plan to breastfeed. It is not known if HYMPAVZI passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
If you inject too much HYMPAVZI, call your healthcare provider or the Poison Help Line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:blood clots (thromboembolic events). HYMPAVZI may increase the risk for your blood to clot in blood vessels in your arm, leg, lung, or head, which can be life-threatening. Blood clots have happened in people using HYMPAVZI. You may have an increased risk of blood clots if you have certain risk factors. Stop using HYMPAVZI and get medical help right away if you develop any of these signs or symptoms of blood clots:
swelling or pain in your arms or legs
redness or discoloration in your arms or legs
shortness of breath
pain in chest or upper back
fast heart rate
cough up blood
feeling faint
headache
numbness in your face
eye pain or swelling
trouble seeing
allergic reactions. HYMPAVZI may cause allergic reactions, including rash and itching. Stop using HYMPAVZI and get medical help right away if you develop any of the following symptoms of a severe allergic reaction:
swelling of your face, lips, mouth, or tongue
trouble breathing
wheezing
dizziness or fainting
fast heartbeat or pounding in your chest
sweating
swelling, hardening, redness, bruising, bleeding, and pain at injection site
headache
fever
joint pain
diarrhea
itching
rash
These are not all the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
What is HYMPAVZI?HYMPAVZI is a prescription medicine used regularly to prevent or reduce the frequency of bleeding episodes in adults and children 6 years of age and older with:
hemophilia A with or without factor VIII inhibitors, or
hemophilia B with or without factor IX inhibitors.
It is not known if HYMPAVZI is safe and effective in people receiving ongoing Immune Tolerance Induction (ITI).
It is not known if HYMPAVZI is safe and effective in children younger than 6 years of age.
]]>Listen now and subscribe to BloodStream wherever you get your podcasts so you do not miss what is coming next.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Listen now and subscribe to BloodStream wherever you get your podcasts so you do not miss what is coming next.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Amy and Patrick sit down with Joe Stanco, HTC Family Nurse Practitioner and founder of the Hemostasis and Thrombosis Nursing Association, for a candid conversation about today's hemophilia care landscape and where it is headed next. We also unpack what this bipartisan legislation could mean for access, research, education, and equity in care.
In this week's I'm Fine segment, we explore the emotional weight of caregiving, the pressure to always show up for others, and what happens when your own care starts to fall to the bottom of the list.
Advocacy, science, and lived experience all in one place. Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Amy and Patrick sit down with Joe Stanco, HTC Family Nurse Practitioner and founder of the Hemostasis and Thrombosis Nursing Association, for a candid conversation about today's hemophilia care landscape and where it is headed next. We also unpack what this bipartisan legislation could mean for access, research, education, and equity in care.
In this week's I'm Fine segment, we explore the emotional weight of caregiving, the pressure to always show up for others, and what happens when your own care starts to fall to the bottom of the list.
Advocacy, science, and lived experience all in one place. Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Maia Meier joins our beloved hosts, Patrick and Amy, to talk about her mission to climb the Seven Summits through Project Elevate Her and bring visibility to women and girls living with bleeding disorders.
From high-altitude expeditions to the everyday realities of advocacy, the conversation explores what it means to take up space in places where women with bleeding disorders have too often gone unseen.
Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
On the latest episode of BloodStream, Maia Meier joins our beloved hosts, Patrick and Amy, to talk about her mission to climb the Seven Summits through Project Elevate Her and bring visibility to women and girls living with bleeding disorders.
From high-altitude expeditions to the everyday realities of advocacy, the conversation explores what it means to take up space in places where women with bleeding disorders have too often gone unseen.
Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Show Notes:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
In I'm Fine, a family story across generations with bleeding disorders traces what has changed, what has not, and how honesty can begin to break cycles of silence that have long been passed down. What emerges is a closer look at resilience, inheritance, and the stories we are taught to minimize.
We close out our plasma donation mini-series with donor Carver, highlighting the people behind every donation and the quiet consistency that keeps treatment possible.
Plasma, perspective, and the moments where silence finally gives way to something more honest. Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
In I'm Fine, a family story across generations with bleeding disorders traces what has changed, what has not, and how honesty can begin to break cycles of silence that have long been passed down. What emerges is a closer look at resilience, inheritance, and the stories we are taught to minimize.
We close out our plasma donation mini-series with donor Carver, highlighting the people behind every donation and the quiet consistency that keeps treatment possible.
Plasma, perspective, and the moments where silence finally gives way to something more honest. Listen now and subscribe to BloodStream Podcast wherever you get your shows.
Show Notes:Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
We've also got a packed lineup: a look at momentum building at the WFH World Congress, policy progress led by State Senator Joseph Addabbo supporting families with rare disorders, and new momentum in storytelling as Sanofi backs additional documentaries spotlighting rare blood conditions.
Plus, we dig into the bigger picture—how bleeding disorders impact entire families, the role creativity plays when navigating physical limitations, and the isolation that can come with not knowing someone who shares your experience.
And don't miss a spotlight on The Red Ink Project and their virtual screening of Dismissed, a film bringing long-overdue visibility to women and girls with bleeding disorders.
All that and more—this is BloodStream.
NY State Senator Joseph Addabbo steps up for bleeding disorders
Sanofi backs 2 more documentary films about rare blood disorders
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
We've also got a packed lineup: a look at momentum building at the WFH World Congress, policy progress led by State Senator Joseph Addabbo supporting families with rare disorders, and new momentum in storytelling as Sanofi backs additional documentaries spotlighting rare blood conditions.
Plus, we dig into the bigger picture—how bleeding disorders impact entire families, the role creativity plays when navigating physical limitations, and the isolation that can come with not knowing someone who shares your experience.
And don't miss a spotlight on The Red Ink Project and their virtual screening of Dismissed, a film bringing long-overdue visibility to women and girls with bleeding disorders.
All that and more—this is BloodStream.
Show Notes:NY State Senator Joseph Addabbo steps up for bleeding disorders
Sanofi backs 2 more documentary films about rare blood disorders
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Pain, perseverance, and the lessons learned along the way give a rare, unfiltered glimpse into life behind the headlines—reminding us all that every treatment, every donation, and every day matters.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Pain, perseverance, and the lessons learned along the way give a rare, unfiltered glimpse into life behind the headlines—reminding us all that every treatment, every donation, and every day matters.
Show Notes:I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Click here to learn more about SEVENFACT.
Click here to learn more about SEVENFACT.
]]>Our beloved hosts, Patrick and Amy happily welcome Dr. Nathan Connell, hematologist and leading expert in bleeding disorders, for a conversation about the past, present, and future of vWD. Together they explore how our understanding of the condition has evolved since its discovery, the challenges that remain in diagnosis and care, and why awareness still matters for the millions of people worldwide living with vWD.
From early clinical observations to modern treatment approaches, Dr. Connell reflects on the milestones that have shaped care over the last century—and what the next hundred years could hold.
Plus, a preview of what's coming next on BloodStream as we approach World Hemophilia Day.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Our beloved hosts, Patrick and Amy happily welcome Dr. Nathan Connell, hematologist and leading expert in bleeding disorders, for a conversation about the past, present, and future of vWD. Together they explore how our understanding of the condition has evolved since its discovery, the challenges that remain in diagnosis and care, and why awareness still matters for the millions of people worldwide living with vWD.
From early clinical observations to modern treatment approaches, Dr. Connell reflects on the milestones that have shaped care over the last century—and what the next hundred years could hold.
Plus, a preview of what's coming next on BloodStream as we approach World Hemophilia Day.
Show Notes:Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Rocky Williams joins to share the power of positivity and what it truly means to be more than "fine," inspiring the bleeding disorders community to dream bigger, aim higher, and embrace life fully. We also break down a major shift in gene therapy: BioMarin's decision to pull Roctavian from the market, what it means for patients, and why preserving critical clinical data is essential for ongoing research and safety.
Tune in for a conversation that blends science, mindset, and community — because living with bleeding disorders is about more than treatments, it's about life itself.
BioMarin pulls hemophilia gene therapy Roctavian
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Subscribe:
Connect with BloodStream Media:
]]>
Rocky Williams joins to share the power of positivity and what it truly means to be more than "fine," inspiring the bleeding disorders community to dream bigger, aim higher, and embrace life fully. We also break down a major shift in gene therapy: BioMarin's decision to pull Roctavian from the market, what it means for patients, and why preserving critical clinical data is essential for ongoing research and safety.
Tune in for a conversation that blends science, mindset, and community — because living with bleeding disorders is about more than treatments, it's about life itself.
Show Notes:BioMarin pulls hemophilia gene therapy Roctavian
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Subscribe:
Connect with BloodStream Media:
]]>
Plus, a nod to Rare Disease Day, a bit of BloodStream banter, and a preview of what's ahead.
Tune in, share with your community, and as always—take self-care of yourself.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Plus, a nod to Rare Disease Day, a bit of BloodStream banter, and a preview of what's ahead.
Tune in, share with your community, and as always—take self-care of yourself.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Plus, in I'm Fine, we sit down with Anthony, a performer and educator living with a bleeding disorder. From invisible disability to grieving the life you imagined, it's a candid conversation about ambition, identity, and learning to stop blaming yourself for what you can't control.
Global outlook. Personal reckoning. Classic BloodStream.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
Plus, in I'm Fine, we sit down with Anthony, a performer and educator living with a bleeding disorder. From invisible disability to grieving the life you imagined, it's a candid conversation about ambition, identity, and learning to stop blaming yourself for what you can't control.
Global outlook. Personal reckoning. Classic BloodStream.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Subscribe:
Connect with BloodStream Media:
]]>
Patrick and Amy welcome Dr. Akshat Jain to talk through the research, the momentum in hematology, and the conversations coming out of this year's meeting. What's generating excitement? What feels meaningful? And what could shape care moving forward for the bleeding disorders community?
If ASH sets the tone for the year ahead, this is your chance to hear how it's sounding.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Patrick and Amy welcome Dr. Akshat Jain to talk through the research, the momentum in hematology, and the conversations coming out of this year's meeting. What's generating excitement? What feels meaningful? And what could shape care moving forward for the bleeding disorders community?
If ASH sets the tone for the year ahead, this is your chance to hear how it's sounding.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Also on this episode of BloodStream, our hosts also look back on the year in gene therapy, spotlighting patients, clinicians, and researchers who are redefining what's possible, including five-year insights from the HOPE-B study in hemophilia B.
This episode is a celebration of hope, trust, and progress—a reminder that hemophilia care isn't just about science, it's about people and the possibilities they create.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World brought to you by @CSLBehring.
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #genetherapy #healthcare #digitalhealth #biotech
https://www.nejm.org/doi/full/10.1056/NEJMoa2514332
Subscribe:
Connect with BloodStream Media:
]]>
Also on this episode of BloodStream, our hosts also look back on the year in gene therapy, spotlighting patients, clinicians, and researchers who are redefining what's possible, including five-year insights from the HOPE-B study in hemophilia B.
This episode is a celebration of hope, trust, and progress—a reminder that hemophilia care isn't just about science, it's about people and the possibilities they create.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World brought to you by @CSLBehring.
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #genetherapy #healthcare #digitalhealth #biotech
Show Notes: Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B
https://www.nejm.org/doi/full/10.1056/NEJMoa2514332
Subscribe:
Connect with BloodStream Media:
]]>
Also featured, a powerful I'm Fine segment with Makenna Dietrich, who shares how "I'm fine" can hide anxiety and inaction, and why waiting has a cost. Her story is a reminder that speaking up and seeking support can bring clarity and change.
Together, these stories capture a year defined by honesty, courage, and a deeper understanding of what progress really asks of us.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Subscribe:
Connect with BloodStream Media:
]]>
Also featured, a powerful I'm Fine segment with Makenna Dietrich, who shares how "I'm fine" can hide anxiety and inaction, and why waiting has a cost. Her story is a reminder that speaking up and seeking support can bring clarity and change.
Together, these stories capture a year defined by honesty, courage, and a deeper understanding of what progress really asks of us.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Gene Therapy Segment
It's a Whole New World brought to you by @CSLBehring.
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #genetherapy #healthcare #digitalhealth #biotech
To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Gene Therapy Segment
It's a Whole New World brought to you by @CSLBehring.
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #genetherapy #healthcare #digitalhealth #biotech
Show Notes:To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B
Subscribe:
Connect with BloodStream Media:
]]>
Together, their stories offer honest, grounded insights into balancing responsibilities, navigating health challenges, and finding your footing when life keeps shifting.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Rareblooddisorders.com
Subscribe:
Connect with BloodStream Media:
]]>
Together, their stories offer honest, grounded insights into balancing responsibilities, navigating health challenges, and finding your footing when life keeps shifting.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Show Notes:Rareblooddisorders.com
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
To meet members of the community and to hear more about their hemophilia A journey, head
to www.hemophiliacommunity.com
Subscribe:
Connect with BloodStream Media:
]]>
Tune in and join us in reflecting on where we've been, where we are, and where our community is heading next.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
"I'm Fine" Segment
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Portraits of Progress: https://www.portraitsofprogress.com/
HFA Voice of Community: https://www.hemophiliafed.org/voice-of-the-community/
Subscribe:
Connect with BloodStream Media:
]]>
Tune in and join us in reflecting on where we've been, where we are, and where our community is heading next.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
"I'm Fine" Segment
I'm Fine is presented by @SanofiUS
#bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy
Show Notes:Portraits of Progress: https://www.portraitsofprogress.com/
HFA Voice of Community: https://www.hemophiliafed.org/voice-of-the-community/
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Global Action Network for Sickle Cell and Other Inherited Blood Disorders
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:Global Action Network for Sickle Cell and Other Inherited Blood Disorders
Subscribe:
Connect with BloodStream Media:
]]>
Patty Weltin and the Beyond the Diagnosis exhibit show how artists bring portraits of children with life-altering diseases to life. These works travel to hospitals, medical schools, galleries, and museums, raising awareness and sparking connection.
Hanna sits down with genetic counselor Kaylee Dollarshell to talk gene therapy—the science, the emotions, and the big decisions families face. A real, behind-the-scenes look at navigating this treatment.
Next time: Hear from Else and Ann Kendall of The Red Ink Project, sharing stories that will challenge how you think about patient advocacy.
Don't miss this episode packed with insight, inspiration, and real stories shaping the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
https://www.beyondthediagnosis.org/
https://findageneticcounselor.nsgc.org/?reload=timezone
Subscribe:
Connect with BloodStream Media:
]]>
Patty Weltin and the Beyond the Diagnosis exhibit show how artists bring portraits of children with life-altering diseases to life. These works travel to hospitals, medical schools, galleries, and museums, raising awareness and sparking connection.
Hanna sits down with genetic counselor Kaylee Dollarshell to talk gene therapy—the science, the emotions, and the big decisions families face. A real, behind-the-scenes look at navigating this treatment.
Next time: Hear from Else and Ann Kendall of The Red Ink Project, sharing stories that will challenge how you think about patient advocacy.
Don't miss this episode packed with insight, inspiration, and real stories shaping the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Show Notes:https://www.beyondthediagnosis.org/
https://findageneticcounselor.nsgc.org/?reload=timezone
Subscribe:
Connect with BloodStream Media:
]]>
Join us for real conversations, patient perspectives, and insights on gene therapy, joint health, and life in the bleeding disorders community.
Next up: An inspiring interview with Patty Weltin and the "Beyond the Diagnosis" art exhibit.
Don't miss this insightful, energizing episode that dives into the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Subscribe:
Connect with BloodStream Media:
]]>
Join us for real conversations, patient perspectives, and insights on gene therapy, joint health, and life in the bleeding disorders community.
Next up: An inspiring interview with Patty Weltin and the "Beyond the Diagnosis" art exhibit.
Don't miss this insightful, energizing episode that dives into the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Star's Pivotal Phase 3 Study (VIVID-6) Initiated:
VGA039 is the first subcutaneous therapy, dosed once monthly, that has the potential to address all types of VWD and all types of bleeds. It has also received Fast Track and orphan drug designation from the United States Food and Drug Administration (FDA). The additional investment announced today supports our continued global clinical expansion as we advance into our pivotal, Phase 3 trial.
Explore clinical trial eligibility: visit THIS WEBSITE
To participate in the first validated VWD quality of life patient-reported outcome tool, please e-mail Judith.Monickaraj@chet.rochester.edu to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Star's Pivotal Phase 3 Study (VIVID-6) Initiated:
VGA039 is the first subcutaneous therapy, dosed once monthly, that has the potential to address all types of VWD and all types of bleeds. It has also received Fast Track and orphan drug designation from the United States Food and Drug Administration (FDA). The additional investment announced today supports our continued global clinical expansion as we advance into our pivotal, Phase 3 trial.
Explore clinical trial eligibility: visit THIS WEBSITE
To participate in the first validated VWD quality of life patient-reported outcome tool, please e-mail Judith.Monickaraj@chet.rochester.edu to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Don't miss this insightful, energizing episode that dives into the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Don't miss this insightful, energizing episode that dives into the future of bleeding disorders care.
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
http://www.linkedin.com/in/edward-rogoff-6624366
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:http://www.linkedin.com/in/edward-rogoff-6624366
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Jeffrey Moualim, Barbara Forss and Joanna Davis, M.D., discussion is in conjunction with CHESFoundation/LadyBugs Program
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>Jeffrey Moualim, Barbara Forss and Joanna Davis, M.D., discussion is in conjunction with CHESFoundation/LadyBugs Program
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Watch the trailer for the latest season!
AWARDS & HONORS
2018 LA Web Fest - Best Premise for a Comedy Series (Winner); Best Cinematography, Best Editing (Nomination)
2017 Imagen Awards - Best Web Series (Nomination)
2017 Brooklyn Web Fest - Best Ensemble (Nomination)
2014 National Hemophilia Foundation - Meritorious Service Award (Winner)
2013 Hemophilia Federation of America - Health & Wellness Award (Winner)
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Watch the trailer for the latest season!
AWARDS & HONORS
2018 LA Web Fest - Best Premise for a Comedy Series (Winner); Best Cinematography, Best Editing (Nomination)
2017 Imagen Awards - Best Web Series (Nomination)
2017 Brooklyn Web Fest - Best Ensemble (Nomination)
2014 National Hemophilia Foundation - Meritorious Service Award (Winner)
2013 Hemophilia Federation of America - Health & Wellness Award (Winner)
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:
Visit Hope Runs Red and watch or share your story!
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Segment is brought to you by Genentech: Visit www.hemashort.com to watch the short film.
Show Notes:
Visit Hope Runs Red and watch or share your story!
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Medicaid Cuts - Take Action Today!
Please call or email the offices you visited in March and remind your lawmakers that Medicaid is a lifeline: ask them to reject Medicaid funding cuts and other policies that would reduce coverage and disrupt care. For email, contact the staffer you met with at Washington Days (check your sent mail for the thank you notes). If you no longer have contact information for your lawmakers' offices, you can call the Capitol switchboard at 202.224.3121 and ask them to connect you. Say or email:
I am [calling/emailing] as a member of the bleeding disorders community and as a constituent to ask you to reject cuts to federal Medicaid funding. I am relying on you, as my Senator/Representative in Congress, to protect Medicaid from funding cuts and other policies that would reduce coverage and care.
Medicaid covers life-sustaining treatment and care for up to one-third of the bleeding disorders community. Without Medicaid, low-income people with bleeding disorders will have no access to the regular care they need to prevent or treat painful, debilitating, and potentially life-threatening bleeding episodes. People will experience preventable health complications – and overall healthcare costs will rise.
Please stand with the bleeding disorders community and so many others who rely on Medicaid, and reject cuts to this program that provides essential coverage to vulnerable individuals across the country.
**
Hemab Therapeutics Announces Start of Velora Pioneer, a Phase 1/2 Clinical Trial Investigating HMB-002 for the Treatment of Von Willebrand Disease: Press Release
More information about the vWD clinical trial participation
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Medicaid Cuts - Take Action Today!
Please call or email the offices you visited in March and remind your lawmakers that Medicaid is a lifeline: ask them to reject Medicaid funding cuts and other policies that would reduce coverage and disrupt care. For email, contact the staffer you met with at Washington Days (check your sent mail for the thank you notes). If you no longer have contact information for your lawmakers' offices, you can call the Capitol switchboard at 202.224.3121 and ask them to connect you. Say or email:
I am [calling/emailing] as a member of the bleeding disorders community and as a constituent to ask you to reject cuts to federal Medicaid funding. I am relying on you, as my Senator/Representative in Congress, to protect Medicaid from funding cuts and other policies that would reduce coverage and care.
Medicaid covers life-sustaining treatment and care for up to one-third of the bleeding disorders community. Without Medicaid, low-income people with bleeding disorders will have no access to the regular care they need to prevent or treat painful, debilitating, and potentially life-threatening bleeding episodes. People will experience preventable health complications – and overall healthcare costs will rise.
Please stand with the bleeding disorders community and so many others who rely on Medicaid, and reject cuts to this program that provides essential coverage to vulnerable individuals across the country.
**
Hemab Therapeutics Announces Start of Velora Pioneer, a Phase 1/2 Clinical Trial Investigating HMB-002 for the Treatment of Von Willebrand Disease: Press Release
More information about the vWD clinical trial participation
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
To learn more about Trevor and hear his music, visit trevormartinmusic.com
To learn more about Trevor Martin's treatment, visit Hemlibra.com
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
To learn more about Trevor and hear his music, visit trevormartinmusic.com
To learn more about Trevor Martin's treatment, visit Hemlibra.com
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
The CDC cuts are of particular concern to our community. The Division of Blood Disorders' work traces back to the 1980s' tainted blood crisis, when CDC investigators were the first to discern and warn of HIV's transmissibility through blood and blood products. To this day, the Division serves the bleeding disorders community and the nation at large through its public health surveillance activities – including maintaining a laboratory with blood samples dating back to 1996. The Division also funds the collection of key data on bleeding disorders through its "Community Counts" program, and supports educational outreach to increase patient and provider understanding of hemophilia and its complications. Elimination of the Division, its clinical repository, and its institutional knowledge would be a huge loss for the bleeding disorders community.
WHAT CAN YOU DO?
Call the Capitol switchboard: (202) 224-3121
*Anyone can call this number and get connected with their Senators and Representative.
I am calling as a member of the bleeding disorders community and as a constituent to ask that you protect the federal hemophilia programs at the CDC. The recent HHS restructuring eliminated essentially all of the staff at the CDC's Division of Blood Disorders, where the hemophilia programs are housed. These programs:
Help to collect important data on bleeding disorders which in turn helps lead to new and more effective treatments.
Provide funding for education and outreach to increase patient and provider understanding of hemophilia.
Help to protect the safety of our nation's blood supply.
I'm very worried about what this means for people with bleeding disorders and our country.
Please work to restore the staffing and activities of the CDC Division of Blood Disorders.
I am relying on you, as my Senator/Representative in Congress, to take action to ensure that the staff for this program are reinstated and to work to protect the funding for this critical program.
**
For years, people with hemophilia A waited for a cure, while inhibitor patients were left behind—but now, after setbacks and failed launches of several gene therapies, investors think patients aren't interested. By taking this short survey, you can make your voice heard and show investors that our community still wants a durable gene therapy, but this time for both hemophilia A with or without inhibitors. Take the survey here
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
The CDC cuts are of particular concern to our community. The Division of Blood Disorders' work traces back to the 1980s' tainted blood crisis, when CDC investigators were the first to discern and warn of HIV's transmissibility through blood and blood products. To this day, the Division serves the bleeding disorders community and the nation at large through its public health surveillance activities – including maintaining a laboratory with blood samples dating back to 1996. The Division also funds the collection of key data on bleeding disorders through its "Community Counts" program, and supports educational outreach to increase patient and provider understanding of hemophilia and its complications. Elimination of the Division, its clinical repository, and its institutional knowledge would be a huge loss for the bleeding disorders community.
WHAT CAN YOU DO?
Call the Capitol switchboard: (202) 224-3121
*Anyone can call this number and get connected with their Senators and Representative.
I am calling as a member of the bleeding disorders community and as a constituent to ask that you protect the federal hemophilia programs at the CDC. The recent HHS restructuring eliminated essentially all of the staff at the CDC's Division of Blood Disorders, where the hemophilia programs are housed. These programs:
Help to collect important data on bleeding disorders which in turn helps lead to new and more effective treatments.
Provide funding for education and outreach to increase patient and provider understanding of hemophilia.
Help to protect the safety of our nation's blood supply.
I'm very worried about what this means for people with bleeding disorders and our country.
Please work to restore the staffing and activities of the CDC Division of Blood Disorders.
I am relying on you, as my Senator/Representative in Congress, to take action to ensure that the staff for this program are reinstated and to work to protect the funding for this critical program.
**
For years, people with hemophilia A waited for a cure, while inhibitor patients were left behind—but now, after setbacks and failed launches of several gene therapies, investors think patients aren't interested. By taking this short survey, you can make your voice heard and show investors that our community still wants a durable gene therapy, but this time for both hemophilia A with or without inhibitors. Take the survey here
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Please share this survey with any friends you have with hemophilia A with or without inhibitors, who will help us educate the investment community on the need for new and better therapies.
$50 gift card to each of the first 50 survey respondents!
https://www.surveymonkey.com/r/geneventiv-2
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Please share this survey with any friends you have with hemophilia A with or without inhibitors, who will help us educate the investment community on the need for new and better therapies.
$50 gift card to each of the first 50 survey respondents!
https://www.surveymonkey.com/r/geneventiv-2
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
I'm Fine is presented by @SanofiUS
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Learn more about survey for the bleeding disorder community from Rare Patient Voice at www.rarepatientvoice.com
Check out Corbin Whittington's LinkedIn page
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Learn more about survey for the bleeding disorder community from Rare Patient Voice at www.rarepatientvoice.com
Check out Corbin Whittington's LinkedIn page
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
It's a Whole New World brought to you by @CSLBehring.
The 1 out of 20 Podcast featuring PJL
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
It's a Whole New World brought to you by @CSLBehring.
The 1 out of 20 Podcast featuring PJL
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Check out season 14 of Stop the Bleeding!
To learn more about our advocacy digital storytelling platform, Voices for Policy Change, head over to www.bleeding.org
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
It's a Whole New World brought to you by @CSLBehring.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
It's a Whole New World brought to you by @CSLBehring.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Want more information on Alternate Funding Programs? Roland said to Google it.
But, here's some more stuff:
HFA Project ECHO: Recognition and Care of Women with Bleeding Disorders
Oct 28 2024, 12:00 pm - 1:00 pm EST
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Genentech Patient Foundation is dedicated to making sure that people with hemophilia A can get access to treatment. No matter what type of health insurance you have, and even if you have none at all, there may be some potential options available to help you afford your medicine.
To learn more about these resources and find out if you are eligible, visit www.HemophiliaAccess.com
Connect with BloodStream Media:
]]>Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Want more information on Alternate Funding Programs? Roland said to Google it.
But, here's some more stuff:
HFA Project ECHO: Recognition and Care of Women with Bleeding Disorders
Oct 28 2024, 12:00 pm - 1:00 pm EST
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Genentech Patient Foundation is dedicated to making sure that people with hemophilia A can get access to treatment. No matter what type of health insurance you have, and even if you have none at all, there may be some potential options available to help you afford your medicine.
To learn more about these resources and find out if you are eligible, visit www.HemophiliaAccess.com
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Help celebrate International Plasma Awareness Week!
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Help celebrate International Plasma Awareness Week!
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about Miranda and others in the hemophilia community, please visit www.treathemA.com
I'm Fine is presented by @SanofiUS
What We Wished We Could Be film: Website - Instagram - Trailer
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about Miranda and others in the hemophilia community, please visit www.treathemA.com
I'm Fine is presented by @SanofiUS
What We Wished We Could Be film: Website - Instagram - Trailer
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
To read "What are fibrinogen disorders?" PDF, CLICK HERE.
Tammy's documentary Compromised: Life without Immunity
I'm Fine is presented by @SanofiUS
Listen to the Global Hemophilia Report
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
To read "What are fibrinogen disorders?" PDF, CLICK HERE.
Tammy's documentary Compromised: Life without Immunity
I'm Fine is presented by @SanofiUS
Listen to the Global Hemophilia Report
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about the FDA's Rare Disease Innovation Hub: EveryLife Foundation
Visit NBDF's Steps for Living
Brandon Young's Country Boy Fishing
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
To learn more about the FDA's Rare Disease Innovation Hub: EveryLife Foundation
Visit NBDF's Steps for Living
Brandon Young's Country Boy Fishing
I'm Fine is presented by @SanofiUS
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Hemophilia Uncensored Social Media: Instagram & TikTok
How the U.S. can close longstanding racial health equity gaps
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Show Notes:
Subscribe:
Hemophilia Uncensored Social Media: Instagram & TikTok
How the U.S. can close longstanding racial health equity gaps
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes with Hemophilia are presented by @SanofiUS
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes with Hemophilia are presented by @SanofiUS
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>If you'd like to learn more about polycythemia vera, check out our sister show PV Pod: Stories from the Marrow (brought to you by BloodStream Media and PharmaEssentia).
Connect with BloodStream Media:
]]>If you'd like to learn more about polycythemia vera, check out our sister show PV Pod: Stories from the Marrow (brought to you by BloodStream Media and PharmaEssentia).
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
On the Shoulders of Giants Film
Watch the movie and host a screening: ontheshouldersfilm.com
Beyond our Blood
Watch the short films and download the facilitation guide: beyondourblood.com
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Check out the Everyday Life Foundation hosting Bombardier Blood
Everyday Life Foundation Legislative Asks
This Rare Disease Day segment is brought to you by Genentech. Genentech has several resources to help caregivers navigate hemophilia including stories from other members in the community. Please visit www.thecommunityhelps.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Check out the Everyday Life Foundation hosting Bombardier Blood
Everyday Life Foundation Legislative Asks
This Rare Disease Day segment is brought to you by Genentech. Genentech has several resources to help caregivers navigate hemophilia including stories from other members in the community. Please visit www.thecommunityhelps.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
To learn more about the Committee of Ten Thousand and to get involved, visit www.COTT1.org
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
To learn more about the Committee of Ten Thousand and to get involved, visit www.COTT1.org
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Join the Movement - Equity for Women with Bleeding Disorders
CHES - Programs for Women with Bleeding Disorders
Take Action Today! - Click HERE
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Join the Movement - Equity for Women with Bleeding Disorders
CHES - Programs for Women with Bleeding Disorders
Take Action Today! - Click HERE
It's a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Segment brought to you by Genentech, please visit www.treathemA.com to learn more.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine is presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Segment brought to you by Genentech, please visit www.treathemA.com to learn more.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
Connect with BloodStream Media:
]]>
Dive deep into the critical history, medical background, and foundational insights of Paroxysmal Nocturnal Hemoglobinuria (PNH) in our inaugural episode. Join us as we set the stage for a comprehensive exploration of this rare blood disorder.
Content Independently Created by Bloodstream Media. Novartis is our exclusive advertising partner.
Subscribe to PNH: Facts, Fiction & FYI.
]]>Dive deep into the critical history, medical background, and foundational insights of Paroxysmal Nocturnal Hemoglobinuria (PNH) in our inaugural episode. Join us as we set the stage for a comprehensive exploration of this rare blood disorder.
Content Independently Created by Bloodstream Media. Novartis is our exclusive advertising partner.
Subscribe to PNH: Facts, Fiction & FYI.
]]>Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes with Hemophilia are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
WFH statement on the Israel-Palestine crisis
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine and Elite Athletes with Hemophilia are presented by @SanofiUS
Sanofi seeks to expand the idea of what's possible for the hemophilia community. Take a deeper look at the science behind hemophilia and an important connection between factor activity levels and potential activities at LevelsMatter.com
Sanofi aims to raise the bar for the patients living with hemophilia. Reimagine what's possible by visiting Rareblooddisorders.com to hear more about Sanofi's dedication to the bleeding disorder community.
Watch "I'm Fine": A panel discussion webinar led by Patrick with The National Bleeding Disorders Foundation
WFH statement on the Israel-Palestine crisis
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
To support CHES's program for women with bleeding disorders, to attend CHES events for individuals and families in the inhibitor community. Or simply to get in touch with comments and ideas please reach out to us at www.ches.education
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
To support CHES's program for women with bleeding disorders, to attend CHES events for individuals and families in the inhibitor community. Or simply to get in touch with comments and ideas please reach out to us at www.ches.education
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes and I'm Fine segments presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes and I'm Fine segments presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Back to School Resources at Steps for Living
Sickle Awareness Month Resources
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes segment presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Back to School Resources at Steps for Living
Sickle Awareness Month Resources
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes segment presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes segment presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Watch Redefining Impossible for free HERE
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Elite Athletes segment presented by @Sanofi
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine presented by @Sanofi Take a deeper at LevelsMatter.com.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
I'm Fine presented by @Sanofi Take a deeper at LevelsMatter.com.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
You can do three practical things to help further the campaign for better treatment for women with bleeding disorders:
1) sign the petition at change.org: Demand Equity in Healthcare for Women
2) Head over to CHES to submit your recommendations for good doctors and hospitals
3) Sign the 'MASAC Document 264' recommendations at hemophilia.org
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>Show Notes:
Subscribe:
You can do three practical things to help further the campaign for better treatment for women with bleeding disorders:
1) sign the petition at change.org: Demand Equity in Healthcare for Women
2) Head over to CHES to submit your recommendations for good doctors and hospitals
3) Sign the 'MASAC Document 264' recommendations at hemophilia.org
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Listen to The Final Summit Season 2 Podcast!
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Listen to The Final Summit Season 2 Podcast!
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Listen and Subscribe to the FLOW podcast!
Share your FLOW story with us! How's Your Flow Calendly
Tik Tok @howsyourflow
Instagram @howsyourflow
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Listen and Subscribe to the FLOW podcast!
Share your FLOW story with us! How's Your Flow Calendly
Tik Tok @howsyourflow
Instagram @howsyourflow
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media:
]]>